Biolife Solutions Inc (NASDAQ: BLFS) started the day on Wednesday, with a price increase of 5.68% at $26.25, before settling in for the price of $24.84 at the close. Taking a more long-term approach, BLFS posted a 52-week range of $14.84-$29.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 42.91% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -55.83%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 57.50%. This publicly-traded company’s shares outstanding now amounts to $46.91 million, simultaneously with a float of $45.48 million. The organization now has a market capitalization sitting at $1.23 billion. At the time of writing, stock’s 50-day Moving Average stood at $26.65, while the 200-day Moving Average is $24.31.
Biolife Solutions Inc (BLFS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Instruments & Supplies Industry. Biolife Solutions Inc’s current insider ownership accounts for 3.24%, in contrast to 101.10% institutional ownership. According to the most recent insider trade that took place on Mar 03 ’25, this organization’s Chief Technology Officer sold 136 shares at the rate of 25.46, making the entire transaction reach 3,463 in total value, affecting insider ownership by 4,953. Preceding that transaction, on Mar 04 ’25, Company’s Chief Technology Officer sold 88 for 24.03, making the whole transaction’s value amount to 2,115. This particular insider is now the holder of 4,865 in total.
Biolife Solutions Inc (BLFS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
Biolife Solutions Inc’s EPS increase for this current 12-month fiscal period is 57.50% and is forecasted to reach 0.13 in the upcoming year.
Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators
Let’s observe the current performance indicators for Biolife Solutions Inc (BLFS). It’s Quick Ratio in the last reported quarter now stands at 3.66. The Stock has managed to achieve an average true range (ATR) of 1.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.89. Similarly, its price to free cash flow for trailing twelve months is now 237.26.
In the same vein, BLFS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.26, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be 0.13 at the market close of one year from today.
Technical Analysis of Biolife Solutions Inc (BLFS)
If we take a close look at the recent performances of Biolife Solutions Inc (NASDAQ: BLFS), its last 5-days Average volume was 0.41 million that shows progress from its year to date volume of 0.27 million. During the previous 9 days, stock’s Stochastic %D was recorded 38.33% While, its Average True Range was 1.63.
Raw Stochastic average of Biolife Solutions Inc (BLFS) in the period of the previous 100 days is set at 67.30%, which indicates a major rise in contrast to 51.89% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 48.80% that was lower than 51.19% volatility it exhibited in the past 100-days period.
